A prospective observational cohort study of HIV infection in Indonesia: baseline characteristics and one-year mortality

Abstract Introduction The incidence rate of newly diagnosed HIV infection in Indonesia decreased from 21 per 100,000 in 2011 to 10 per 100,000 in 2021. Despite this progress, AIDS-related deaths among people living with HIV (PLWH) increased from 3.4% in 2010 to 4.8% in 2020. Determining risk factors...

Full description

Saved in:
Bibliographic Details
Main Authors: Tuti P. Merati, Evy Yunihastuti, Rudi Wisaksana, Nia Kurniati, Dona Arlinda, Muhammad Karyana, Nugroho H. Susanto, Dewi Lokida, Herman Kosasih, Aly Diana, Lois E. Bang, Melinda Setiyaningrum, Desrinawati M. Amin, Eppy Eppy, Wiwit A. S. N. Cahyawati, Emon W. Danudirgo, I Made Gede Darmaja, Nur Farhanah, Carta A. Gunawan, Usman Hadi, Kurnia F. Jamil, Sudirman Katu, Tambar Kembaren, I Gede Rai Kosa, Danang L. Norosingomurti, Asep Purnama, Ida S. Laksanawati, Adria Rusli, I Ketut Agus Somia, Yanri W. Subronto, Ivan L. Toruan, Renee Ridzon, C. Jason Liang, Aaron T. Neal, Ray Y. Chen, INA-PROACTIVE Study Group
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-024-10354-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586020486381568
author Tuti P. Merati
Evy Yunihastuti
Rudi Wisaksana
Nia Kurniati
Dona Arlinda
Muhammad Karyana
Nugroho H. Susanto
Dewi Lokida
Herman Kosasih
Aly Diana
Lois E. Bang
Melinda Setiyaningrum
Desrinawati M. Amin
Eppy Eppy
Wiwit A. S. N. Cahyawati
Emon W. Danudirgo
I Made Gede Darmaja
Nur Farhanah
Carta A. Gunawan
Usman Hadi
Kurnia F. Jamil
Sudirman Katu
Tambar Kembaren
I Gede Rai Kosa
Danang L. Norosingomurti
Asep Purnama
Ida S. Laksanawati
Adria Rusli
I Ketut Agus Somia
Yanri W. Subronto
Ivan L. Toruan
Renee Ridzon
C. Jason Liang
Aaron T. Neal
Ray Y. Chen
INA-PROACTIVE Study Group
author_facet Tuti P. Merati
Evy Yunihastuti
Rudi Wisaksana
Nia Kurniati
Dona Arlinda
Muhammad Karyana
Nugroho H. Susanto
Dewi Lokida
Herman Kosasih
Aly Diana
Lois E. Bang
Melinda Setiyaningrum
Desrinawati M. Amin
Eppy Eppy
Wiwit A. S. N. Cahyawati
Emon W. Danudirgo
I Made Gede Darmaja
Nur Farhanah
Carta A. Gunawan
Usman Hadi
Kurnia F. Jamil
Sudirman Katu
Tambar Kembaren
I Gede Rai Kosa
Danang L. Norosingomurti
Asep Purnama
Ida S. Laksanawati
Adria Rusli
I Ketut Agus Somia
Yanri W. Subronto
Ivan L. Toruan
Renee Ridzon
C. Jason Liang
Aaron T. Neal
Ray Y. Chen
INA-PROACTIVE Study Group
author_sort Tuti P. Merati
collection DOAJ
description Abstract Introduction The incidence rate of newly diagnosed HIV infection in Indonesia decreased from 21 per 100,000 in 2011 to 10 per 100,000 in 2021. Despite this progress, AIDS-related deaths among people living with HIV (PLWH) increased from 3.4% in 2010 to 4.8% in 2020. Determining risk factors for mortality may identify areas to intervene and reduce mortality. Methods A multicenter, prospective, observational cohort study of HIV infection, coinfections, and comorbidities (INA-PROACTIVE) was carried out at 19 hospitals across major islands in Indonesia. The study enrolled PLWH from 2018–2020 and followed them for 3 years. For this analysis, PLWH ≥ 18 years old with one year of follow-up data were included. Cox regression was used to identify variables at enrollment that correlated with one-year mortality. Results Among the 4,050 PLWH analysed in the study, 68.8% were male, 53.5% acquired HIV through heterosexual transmission, 92.4% were on antiretroviral treatment (ART) at enrollment, and 72.4% had an undetectable viral load. At one year, 115 (2.8%) had died. Detectable viremia at enrollment was significantly associated with mortality, with the risk increasing as the viral load (VL) category increased (adjusted hazard ratio [aHR] 4.47, 95% CI: 1.47–13.56 for VL 50 to < 1,000 copies/mL; aHR 7.88, 95% CI: 2.80–22.20 for VL 1,000 to 10,000 copies/mL; and aHR 18.33, 95% CI: 7.94–42.34 for VL > 10,000 copies/mL; compared to VL < 50 copies/mL). Other factors at enrollment significantly associated with mortality were a CD4 + count < 200 (aHR 8.02, 95% CI: 2.69–23.86; compared to ≥ 350), age 40–49 years (aHR 2.19, 95% CI 1.23–3.87; compared to 18–29 years) and being underweight (aHR 1.84, 95% CI: 1.18–2.85; compared to normal weight). Conclusions Among predominantly treatment-experienced PLWH, detectable viremia and continued immunosuppression were significantly associated with one-year mortality. This study highlights the importance of ART with complete viral suppression as well as immune recovery to prevent mortality. Trial registration Clinical Trial Number: NCT03663920, registration date: 4 January 2018.
format Article
id doaj-art-d9f916dc530c4c05842511be9fa7a96e
institution Kabale University
issn 1471-2334
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-d9f916dc530c4c05842511be9fa7a96e2025-01-26T12:17:06ZengBMCBMC Infectious Diseases1471-23342025-01-0125111310.1186/s12879-024-10354-8A prospective observational cohort study of HIV infection in Indonesia: baseline characteristics and one-year mortalityTuti P. Merati0Evy Yunihastuti1Rudi Wisaksana2Nia Kurniati3Dona Arlinda4Muhammad Karyana5Nugroho H. Susanto6Dewi Lokida7Herman Kosasih8Aly Diana9Lois E. Bang10Melinda Setiyaningrum11Desrinawati M. Amin12Eppy Eppy13Wiwit A. S. N. Cahyawati14Emon W. Danudirgo15I Made Gede Darmaja16Nur Farhanah17Carta A. Gunawan18Usman Hadi19Kurnia F. Jamil20Sudirman Katu21Tambar Kembaren22I Gede Rai Kosa23Danang L. Norosingomurti24Asep Purnama25Ida S. Laksanawati26Adria Rusli27I Ketut Agus Somia28Yanri W. Subronto29Ivan L. Toruan30Renee Ridzon31C. Jason Liang32Aaron T. Neal33Ray Y. Chen34INA-PROACTIVE Study GroupDepartment of Internal Medicine, Faculty of Medicine, Universitas UdayanaFaculty of Medicine, Cipto Mangunkusumo Hospital, Universitas IndonesiaFaculty of Medicine, Hasan Sadikin General Hospital, Universitas PadjadjaranFaculty of Medicine, Cipto Mangunkusumo Hospital, Universitas IndonesiaIndonesia Research Partnership On Infectious Diseases (INA-RESPOND)Indonesia Research Partnership On Infectious Diseases (INA-RESPOND)Indonesia Research Partnership On Infectious Diseases (INA-RESPOND)Indonesia Research Partnership On Infectious Diseases (INA-RESPOND)Indonesia Research Partnership On Infectious Diseases (INA-RESPOND)Indonesia Research Partnership On Infectious Diseases (INA-RESPOND)Indonesia Research Partnership On Infectious Diseases (INA-RESPOND)Indonesia Research Partnership On Infectious Diseases (INA-RESPOND)Prof. Dr. Sulianti Saroso Infectious Disease HospitalPersahabatan Central General HospitalDr. Moch. Ansari Saleh HospitalSt. Carolus HospitalAbepura Regional General HospitalDepartment of Internal Medicine, Faculty of Medicine, Universitas Diponegoro/Dr, Kariadi HospitalFaculty of Medicine, Abdoel Wahab Sjahranie General Hospital, Universitas MulawarmanDepartment of Internal Medicine, Faculty of Medicine, Universitas Airlangga/Dr, Soetomo General Academic HospitalDr. Zainoel Abidin Hospital/Faculty of Medicine, Universitas Syiah KualaDr. Wahidin Sudirohusodo HospitalAdam Malik HospitalTangerang District HospitalBudi Kemuliaan HospitalDr. T. C. Hillers Public HospitalDepartment of Child Health, Dr. Sardjito General Hospital/Faculty of Medicine, Public Health and Nursing, Universitas Gadjah MadaProf. Dr. Sulianti Saroso Infectious Disease HospitalDepartment of Internal Medicine, Faculty of Medicine, Ngoerah Hospital, Universitas UdayanaDepartment of Internal Medicine/Magister of Tropical Medicine Study Program, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr Sardjito General HospitalSoedarso General HospitalNational Institute of Allergy and Infectious Diseases, National Institutes of HealthNational Institute of Allergy and Infectious Diseases, National Institutes of HealthNational Institute of Allergy and Infectious Diseases, National Institutes of HealthNational Institute of Allergy and Infectious Diseases, National Institutes of HealthAbstract Introduction The incidence rate of newly diagnosed HIV infection in Indonesia decreased from 21 per 100,000 in 2011 to 10 per 100,000 in 2021. Despite this progress, AIDS-related deaths among people living with HIV (PLWH) increased from 3.4% in 2010 to 4.8% in 2020. Determining risk factors for mortality may identify areas to intervene and reduce mortality. Methods A multicenter, prospective, observational cohort study of HIV infection, coinfections, and comorbidities (INA-PROACTIVE) was carried out at 19 hospitals across major islands in Indonesia. The study enrolled PLWH from 2018–2020 and followed them for 3 years. For this analysis, PLWH ≥ 18 years old with one year of follow-up data were included. Cox regression was used to identify variables at enrollment that correlated with one-year mortality. Results Among the 4,050 PLWH analysed in the study, 68.8% were male, 53.5% acquired HIV through heterosexual transmission, 92.4% were on antiretroviral treatment (ART) at enrollment, and 72.4% had an undetectable viral load. At one year, 115 (2.8%) had died. Detectable viremia at enrollment was significantly associated with mortality, with the risk increasing as the viral load (VL) category increased (adjusted hazard ratio [aHR] 4.47, 95% CI: 1.47–13.56 for VL 50 to < 1,000 copies/mL; aHR 7.88, 95% CI: 2.80–22.20 for VL 1,000 to 10,000 copies/mL; and aHR 18.33, 95% CI: 7.94–42.34 for VL > 10,000 copies/mL; compared to VL < 50 copies/mL). Other factors at enrollment significantly associated with mortality were a CD4 + count < 200 (aHR 8.02, 95% CI: 2.69–23.86; compared to ≥ 350), age 40–49 years (aHR 2.19, 95% CI 1.23–3.87; compared to 18–29 years) and being underweight (aHR 1.84, 95% CI: 1.18–2.85; compared to normal weight). Conclusions Among predominantly treatment-experienced PLWH, detectable viremia and continued immunosuppression were significantly associated with one-year mortality. This study highlights the importance of ART with complete viral suppression as well as immune recovery to prevent mortality. Trial registration Clinical Trial Number: NCT03663920, registration date: 4 January 2018.https://doi.org/10.1186/s12879-024-10354-8HIVIndonesiaMortalityRisk factorsAdult cohortViremia
spellingShingle Tuti P. Merati
Evy Yunihastuti
Rudi Wisaksana
Nia Kurniati
Dona Arlinda
Muhammad Karyana
Nugroho H. Susanto
Dewi Lokida
Herman Kosasih
Aly Diana
Lois E. Bang
Melinda Setiyaningrum
Desrinawati M. Amin
Eppy Eppy
Wiwit A. S. N. Cahyawati
Emon W. Danudirgo
I Made Gede Darmaja
Nur Farhanah
Carta A. Gunawan
Usman Hadi
Kurnia F. Jamil
Sudirman Katu
Tambar Kembaren
I Gede Rai Kosa
Danang L. Norosingomurti
Asep Purnama
Ida S. Laksanawati
Adria Rusli
I Ketut Agus Somia
Yanri W. Subronto
Ivan L. Toruan
Renee Ridzon
C. Jason Liang
Aaron T. Neal
Ray Y. Chen
INA-PROACTIVE Study Group
A prospective observational cohort study of HIV infection in Indonesia: baseline characteristics and one-year mortality
BMC Infectious Diseases
HIV
Indonesia
Mortality
Risk factors
Adult cohort
Viremia
title A prospective observational cohort study of HIV infection in Indonesia: baseline characteristics and one-year mortality
title_full A prospective observational cohort study of HIV infection in Indonesia: baseline characteristics and one-year mortality
title_fullStr A prospective observational cohort study of HIV infection in Indonesia: baseline characteristics and one-year mortality
title_full_unstemmed A prospective observational cohort study of HIV infection in Indonesia: baseline characteristics and one-year mortality
title_short A prospective observational cohort study of HIV infection in Indonesia: baseline characteristics and one-year mortality
title_sort prospective observational cohort study of hiv infection in indonesia baseline characteristics and one year mortality
topic HIV
Indonesia
Mortality
Risk factors
Adult cohort
Viremia
url https://doi.org/10.1186/s12879-024-10354-8
work_keys_str_mv AT tutipmerati aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT evyyunihastuti aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT rudiwisaksana aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT niakurniati aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT donaarlinda aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT muhammadkaryana aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT nugrohohsusanto aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT dewilokida aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT hermankosasih aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT alydiana aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT loisebang aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT melindasetiyaningrum aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT desrinawatimamin aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT eppyeppy aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT wiwitasncahyawati aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT emonwdanudirgo aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT imadegededarmaja aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT nurfarhanah aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT cartaagunawan aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT usmanhadi aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT kurniafjamil aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT sudirmankatu aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT tambarkembaren aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT igederaikosa aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT dananglnorosingomurti aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT aseppurnama aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT idaslaksanawati aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT adriarusli aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT iketutagussomia aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT yanriwsubronto aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT ivanltoruan aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT reneeridzon aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT cjasonliang aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT aarontneal aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT rayychen aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT inaproactivestudygroup aprospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT tutipmerati prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT evyyunihastuti prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT rudiwisaksana prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT niakurniati prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT donaarlinda prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT muhammadkaryana prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT nugrohohsusanto prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT dewilokida prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT hermankosasih prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT alydiana prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT loisebang prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT melindasetiyaningrum prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT desrinawatimamin prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT eppyeppy prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT wiwitasncahyawati prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT emonwdanudirgo prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT imadegededarmaja prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT nurfarhanah prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT cartaagunawan prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT usmanhadi prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT kurniafjamil prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT sudirmankatu prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT tambarkembaren prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT igederaikosa prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT dananglnorosingomurti prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT aseppurnama prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT idaslaksanawati prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT adriarusli prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT iketutagussomia prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT yanriwsubronto prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT ivanltoruan prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT reneeridzon prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT cjasonliang prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT aarontneal prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT rayychen prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality
AT inaproactivestudygroup prospectiveobservationalcohortstudyofhivinfectioninindonesiabaselinecharacteristicsandoneyearmortality